Response to duloxetine in patients with knee pain due to osteoarthritis: an exploratory post hoc analysis of a Japanese Phase III randomized study

number of downloads : ?

Use this link to cite this item : https://ir.lib.shimane-u.ac.jp/53218

language	eng
Author	Itoh Naohiro Medical Affairs Department, Shionogi & Co. Ltd, Osaka, Japan Tsuji Toshinaga Medical Affairs Department, Shionogi & Co. Ltd, Osaka, Japan Ishida Mitsuhiro Clinical Development Department, Shionogi & Co. Ltd, Osaka, Japan Ochiai Toshimitsu Biostatistics Center, Shionogi & Co. Ltd, Osaka, Japan Konno Shinichi Department of Orthopaedic Surgery, Fukushima Medical University, Fukushima, Japan Uchio, Yuji
Subject	Brief Pain Inventory; responder analysis; WOMAC
Journal Title	JOURNAL OF PAIN RESEARCH
Volume	11
Start Page	2603
End Page	2616
ISSN	1178-7090
Published Date	2018
DOI	10.2147/JPR.S176036
PubMed ID	30464579
Publisher	DOVE MEDICAL PRESS LTD
NII Type	Journal Article
OAI-PMH Set	Faculty of Medicine
Remark	This study was sponsored by Shionogi & Co. Ltd, the manufacturer of duloxetine. Shionogi & Co. Ltd was involved in the study design, data collection, data analysis, preparation of the manuscript, and the decision to submit this manuscript for publication. Medical writing assistance was provided by Rebecca Lew, PhD, CMPP and Hiroko Ebina, BPharm, Ph, MBA of ProScribe - Envision Pharma Group, and was funded by Shionogi & Co. Ltd. ProScribe's services complied with the international guidelines for Good Publication Practice (GPP3).